• The Lancashire Clinical Trials Unit (CTU) has been granted full registration status by the UK Clinical Research Collaboration (UKCRC).
• This recognition positions the Lancashire CTU as the second fully registered unit in the North West Coast region and one of 49 nationally.
• The CTU has contributed to significant trials, including the STIMULATE-ICP Study for long-COVID and the COMMITS trial for stroke recovery.
• Professor Chris Sutton will rejoin the CTU in 2025 to enhance its capabilities, particularly in mental health trials and inclusivity research.